Case Study: Nivalis Therapeutics improves clinical trial experience and patient retention with Greenphire's ClinCard and eClinical GPS

Nivalis Therapeutics Improves the Clinical Trial Experience for Patients and Investigators with an End-to-End Payment Solution

Nivalis Therapeutics, a small biotech focused on developing therapies for cystic fibrosis (CF), ran two clinical trials across more than 45 sites and faced the challenge of minimizing administrative burdens that distract investigators and create barriers for patients and families. Because CF trials involve long-standing patient–caregiver–investigator relationships and sensitive logistics, Nivalis needed a way to streamline reimbursements and reduce friction so teams could stay focused on patient care and trial goals.

Nivalis implemented Greenphire’s eClinical GPS and ClinCard Travel Module to automate site payments and provide immediate patient travel reimbursements. The end-to-end solution simplified cash flow for sites and patients, improved retention and participation, and strengthened site relationships—supporting a better clinical trial experience while letting the small sponsor concentrate on developing therapies.

Nivalis

Robert Hopkins

Senior Director of Clinical Research